Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 442

1.

Insulin glargine and glulisine SoloSTAR pens for the treatment of diabetes.

Garg S, Kelly WC, Garg S.

Expert Rev Med Devices. 2008 Mar;5(2):113-23. doi: 10.1586/17434440.5.2.113. Review.

PMID:
18331174
[PubMed - indexed for MEDLINE]
2.

Dose accuracy and injection force dynamics of a novel disposable insulin pen.

Clarke A, Spollett G.

Expert Opin Drug Deliv. 2007 Mar;4(2):165-74. Review.

PMID:
17335413
[PubMed - indexed for MEDLINE]
3.

Initiating insulin therapy in type 2 diabetes: benefits of insulin analogs and insulin pens.

Brunton S.

Diabetes Technol Ther. 2008 Aug;10(4):247-56. doi: 10.1089/dia.2008.0287. Review.

PMID:
18715198
[PubMed - indexed for MEDLINE]
4.

Insulin delivery with FlexPen: dose accuracy, patient preference and adherence.

Pfützner A, Asakura T, Sommavilla B, Lee W.

Expert Opin Drug Deliv. 2008 Aug;5(8):915-25. doi: 10.1517/17425247.5.8.915 . Review.

PMID:
18713000
[PubMed - indexed for MEDLINE]
5.

Dosing accuracy with a novel pen device (SoloSTAR) as performed by patients with diabetes in a clinical setting.

Hermanns N, Kulzer B, Haak T.

Diabetes Technol Ther. 2008 Aug;10(4):322-7. doi: 10.1089/dia.2008.0035.

PMID:
18715206
[PubMed - indexed for MEDLINE]
6.

Dose accuracy comparison between SoloSTAR and FlexPen at three different dose levels.

Penfornis A, Horvat K.

Diabetes Technol Ther. 2008 Oct;10(5):359-62. doi: 10.1089/dia.2008.0082.

PMID:
18715211
[PubMed - indexed for MEDLINE]
7.

Validation of the SoloSTAR insulin pen.

Schwartz S, Vlajnic A.

Diabetes Technol Ther. 2008 Oct;10(5):351-7. doi: 10.1089/dia.2008.0079.

PMID:
18715210
[PubMed - indexed for MEDLINE]
8.

Usability of a pre-filled insulin injection device in a 3-month observational survey of everyday clinical practice in Australia.

Carter J, Roberts A.

Curr Med Res Opin. 2008 Oct;24(10):2741-9. doi: 10.1185/03007990802367579 . Epub 2008 Aug 19.

PMID:
18715525
[PubMed - indexed for MEDLINE]
10.

A Pan-European and Canadian prospective survey to evaluate patient satisfaction with the SoloSTAR insulin injection device in type 1 and type 2 diabetes.

Hancu N, Czupryniak L, Genestin E, Sourij H.

J Diabetes Sci Technol. 2011 Sep 1;5(5):1224-34.

PMID:
22027323
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label study.

Haak T, Edelman S, Walter C, Lecointre B, Spollett G.

Clin Ther. 2007 Apr;29(4):650-60.

PMID:
17617288
[PubMed - indexed for MEDLINE]
12.

Development of the SoloSTAR insulin pen device: design verification and validation.

Bode A.

Expert Opin Drug Deliv. 2009 Jan;6(1):103-12. doi: 10.1517/17425240802636187 .

PMID:
19236211
[PubMed - indexed for MEDLINE]
13.

Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial.

Bretzel RG, Nuber U, Landgraf W, Owens DR, Bradley C, Linn T.

Lancet. 2008 Mar 29;371(9618):1073-84. doi: 10.1016/S0140-6736(08)60485-7. Erratum in: Lancet. 2008 Aug 30;372(9640):718.

PMID:
18374840
[PubMed - indexed for MEDLINE]
14.

Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.

Pawaskar MD, Camacho FT, Anderson RT, Cobden D, Joshi AV, Balkrishnan R.

Clin Ther. 2007 Jun;29(6 Pt 1):1294-305.

PMID:
18036391
[PubMed - indexed for MEDLINE]
15.

Health care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.

Pawaskar MD, Camacho FT, Anderson RT, Cobden D, Joshi AV, Balkrishnan R.

Clin Ther. 2007;29 Spec No:1294-305.

PMID:
18046929
[PubMed - indexed for MEDLINE]
16.

A review of insulin pen devices.

McCoy EK, Wright BM.

Postgrad Med. 2010 May;122(3):81-8. doi: 10.3810/pgm.2010.05.2145. Review.

PMID:
20463417
[PubMed - indexed for MEDLINE]
17.

Insulin delivery by injection in children and adolescents with diabetes.

Hanas R, de Beaufort C, Hoey H, Anderson B.

Pediatr Diabetes. 2011 Aug;12(5):518-26. doi: 10.1111/j.1399-5448.2010.00731.x. Epub 2011 Apr 11. Review.

PMID:
21481121
[PubMed - indexed for MEDLINE]
18.

Does pen help? A real-world outcomes study of switching from vial to disposable pen among insulin glargine-treated patients with type 2 diabetes mellitus.

Xie L, Zhou S, Wei W, Gill J, Pan C, Baser O.

Diabetes Technol Ther. 2013 Mar;15(3):230-6. doi: 10.1089/dia.2012.0253. Epub 2013 Jan 21.

PMID:
23336845
[PubMed - indexed for MEDLINE]
19.

FlexPen: addressing issues of confidence and convenience in insulin delivery.

Korytkowski M, Niskanen L, Asakura T.

Clin Ther. 2005;27 Suppl B:S89-100. Review.

PMID:
16519040
[PubMed - indexed for MEDLINE]
20.

Addressing barriers to insulin therapy: the role of insulin pens.

Magwire ML.

Am J Ther. 2011 Sep;18(5):392-402. doi: 10.1097/MJT.0b013e3181ef4dde.

PMID:
20838202
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk